- $10.50bn
- $9.59bn
- $570.40m
- 100
- 15
- 92
- 79
Annual balance sheet for Doximity, fiscal year end - March 31st, USD millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 143 | 798 | 841 | 763 | 916 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 50.3 | 81.1 | 112 | 107 | 136 |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 209 | 904 | 975 | 913 | 1,089 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 8.94 | 9.57 | 25.1 | 24.6 | 22.5 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 252 | 991 | 1,137 | 1,079 | 1,264 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 102 | 111 | 140 | 147 | 156 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 104 | 113 | 171 | 178 | 182 |
Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 148 | 879 | 966 | 901 | 1,083 |
Total Liabilities & Shareholders' Equity | 252 | 991 | 1,137 | 1,079 | 1,264 |
Total Common Shares Outstanding |